Vaccination against COVID-19 can reduce the severity and duration of COVID

Published Date: 02 Mar 2023

Vaccination against SARS-CoV-2, the virus that causes COVID-19, can reduce the severity and duration of COVID in people who have persistent symptoms after infection, he said.

Read Full News

Latest News

US Figures Suggest HIV Aid Was Maintained; but Data Show Drops in Testing, Diagnoses

The U.S. State Department on Friday said it had supported HIV treatment for 20.6 million people as of September last year, including 3 million people whose care was...

Integrase Inhibitors May Raise Cardiometabolic Risk in HIV

Switching to integrase strand transfer inhibitors may raise cardiometabolic risk in people living with HIV on stable antiretroviral therapy and with a low-to-moderate cardiovascular risk.

HIV Treatment May Move Beyond Daily Pills With Injectables

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Funding Cuts Challenge Malaria Vaccination Initiatives

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

Global Fund Expands Commitment to Improve Access to HIV Drug

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

The U.S. State Department on Friday said it had supported HIV treatment for 20.6 million people as of September last year, including 3 million people whose care was...

Switching to integrase strand transfer inhibitors may raise cardiometabolic risk in people living with HIV on stable antiretroviral therapy and with a low-to-moderate cardiovascular risk.

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

News All Time

Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection.

Does HIV Status Affect Long COVID Manifestations?

Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

Is Integrase Inhibitor-Based HIV Therapy Safe in Pregnancy?

In utero exposure to integrase inhibitor-based antiretroviral regimens is not associated with adverse 1-year neurodevelopmental outcomes compared with exposure to other antiretroviral regimens.

Nigerian HIV Volunteers Went Door-to-Door Amid Aid Cuts

For several months last year, Josephine Angev walked the dusty village paths of Nigeria's Benue State to help people living with HIV stay on their life-saving medication.

Ryan White: The Safety Net We Cannot Afford to Shrink

Dr Daskalakis shares the important strides that HIV/AIDS care has made and how critical access to care can be for some patients.

Kennedy Allies Petition to Broaden US Vaccine Injury List

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

Kids Confirmed as Top Transmitters of RSV

New modeling data support targeted prevention efforts.

Kent Meningitis Outbreak Triggers Surge in UK Vaccine Demand, Policy Debate

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Parasitic Worms Provide Insights on RSV Prevention

Researchers identify metabolite alternatives to helminth-influenced protection.

Viral Coinfection May Predict Bacteremic Pneumonia

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

UK Says Vaccine Protects Against Strain in Deadly Meningitis Outbreak

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

Sudan Clinics Could Run Out of Supplies Due to Middle East War

Medical supplies to clinics dealing with the humanitarian crisis in Sudan could run out within 2 weeks unless ⁠shipments are rapidly rerouted.

Around 4.9 Million Children Under Five Died in 2024, Says UN

About 4.9 million children died before reaching their fifth birthday in 2024, according to new United Nations estimates, a sign progress ⁠to reduce child mortality rates was...

UK Races to Contain Meningitis Outbreak in Kent After Two Deaths

Britain will roll out meningitis vaccines to students at a university in southeast England after an "unprecedented" outbreak of the disease killed two people while the...

Treating Gonorrhea Orally: Access vs Resistance

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

Starting HIV PrEP in the Second Trimester Appears Safe

In pregnant women testing negative for HIV, second-trimester preexposure prophylaxis with the dapivirine vaginal ring or oral tenofovir disoproxil fumarate-emtricitabine is safe.

Recommended News For You

Sickle Cell Disease Drug Pulled From Global Markets

Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.

High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

Acupuncture may alleviate nocturia in men treated for prostate cancer

TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

Recommended Articles For You

Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency 

The Latest Advances in Glioblastoma Treatment and Prevention  

Tumor Evolution: Signaling, Cancer Cell Plasticity, and Intratumor Heterogeneity 

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chronic pain and poor sleep are troublesome bed partners.

2.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

3.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

4.

Alkem introduces cetuximab under the trade name Cetuxa in India.

5.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

1.

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study

2.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

3.

The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery

4.

Understanding Melanoma: From Diagnosis to Healing and Excision in Denver

5.

The Surprising Role of Magnesium in Digestion, Sleep and Mental Health 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

2.

Navigating the Complexities of Ph Negative ALL - Part IX

3.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

4.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot